{
    "score": [
        1.0
    ],
    "extracted": [
        6
    ],
    "abstract": [
        "idera pharmaceuticals trading up 6.3 % ."
    ],
    "id": "1116936.train",
    "article": [
        "idera pharmaceuticals inc was up 6.3 % during trading on friday . the company traded as high as $ 2.55 and last traded at $ 2.55 . approximately 2,021,726 shares traded hands during trading , an increase of 34 % from the average daily volume of 1,512,508 shares . the stock had previously closed at $ 2.40 . a number of equities research analysts recently commented on idra shares . zacks investment research upgraded idera pharmaceuticals from a `` sell '' rating to a `` hold '' rating in a research report on wednesday , october 11th . hc wainwright started coverage on idera pharmaceuticals in a research report on thursday , november 9th . ",
        "they set a `` buy '' rating and a $ 4.00 price target on the stock . finally , bidaskclub lowered idera pharmaceuticals from a `` buy '' rating to a `` hold '' rating in a research report on thursday , december 7th . one equities research analyst has rated the stock with a sell rating , one has given a hold rating , five have issued a buy rating and one has assigned a strong buy rating to the company . idera pharmaceuticals has an average rating of `` buy '' and an average price target of $ 4.83 . ",
        "the stock has a market capitalization of $ 496.92 , a pe ratio of -7.50 and a beta of 2.19 . idera pharmaceuticals last released its quarterly earnings results on monday , november 6th . the biotechnology company reported eps for the quarter , topping the zacks ' consensus estimate of by $ 0.02 . idera pharmaceuticals had a negative return on equity of 60.80 % and a negative net margin of 313.78 % . the business had revenue of $ 0.16 million for the quarter , compared to analyst estimates of $ 0.20 million . sell-side analysts expect that idera pharmaceuticals inc will post -0.42 earnings per share for the current year . ",
        "in other news , director bros. . advisors lp baker acquired 8,000,000 shares of idera pharmaceuticals stock in a transaction on thursday , october 26th . the shares were purchased at an average price of $ 1.50 per share , with a total value of $ 12,000,000.00 . the transaction was disclosed in a filing with the sec , which is accessible through this link . also , major shareholder invest corp pillar sold 2,300,000 shares of the company 's stock in a transaction on friday , december 15th . the stock was sold at an average price of $ 1.96 , for a total value of $ 4,508,000.00 . ",
        "the disclosure for this sale can be found here . 12.42 % of the stock is currently owned by corporate insiders . a number of large investors have recently bought and sold shares of the business . vanguard group inc. . lifted its holdings in idera pharmaceuticals by 3.5 % during the 2nd quarter . vanguard group inc. . now owns 5,181,108 shares of the biotechnology company 's stock worth $ 8,911,000 after buying an additional 173,775 shares in the last quarter . jpmorgan chase & co. . lifted its holdings in idera pharmaceuticals by 45.4 % during the 3rd quarter . ",
        "jpmorgan chase & co. . now owns 3,359,875 shares of the biotechnology company 's stock worth $ 7,526,000 after buying an additional 1,048,475 shares in the last quarter . fmr llc lifted its stake in shares of idera pharmaceuticals by 3.8 % in the 2nd quarter . fmr llc now owns 3,274,462 shares of the biotechnology company 's stock valued at $ 5,632,000 after purchasing an additional 120,000 shares during the period . state street corp lifted its stake in shares of idera pharmaceuticals by 13.0 % in the 2nd quarter . state street corp now owns 1,787,852 shares of the biotechnology company 's stock valued at $ 3,075,000 after purchasing an additional 205,217 shares during the period . ",
        "finally , northern trust corp lifted its stake in shares of idera pharmaceuticals by 9.4 % in the 2nd quarter . northern trust corp now owns 1,268,840 shares of the biotechnology company 's stock valued at $ 2,183,000 after purchasing an additional 109,013 shares during the period . 24.14 % of the stock is currently owned by hedge funds and other institutional investors . trademark violation warning : `` idera pharmaceuticals trading up 6.3 % '' was originally published by daily political and is the sole property of of daily political . if you are accessing this piece on another publication , it was illegally stolen and reposted in violation of international copyright legislation . ",
        "the original version of this piece can be accessed at idera pharmaceuticalsidera pharmaceuticals , inc is a clinical-stage biopharmaceutical company focused on the discovery , development and commercialization of therapeutics for oncology and rare diseases . the company utilizes two drug discovery technology platforms to design and develop drug candidates , which include toll-like receptor targeting technology and third-generation antisense technology .   "
    ]
}